IP Case Law › Patents › E.R. Squibb and Sons, LLC & Ors. v. Zydus Lifesciences Limit…
Relevant Acts and provisions
Patents Act, 1970
Section 107Section 107ASection 108Section 48Section 64
Provisions considered: Sections 48, 64, 107, 107A and 108 of the Patents Act, 1970, in a quia timet action concerning a biosimilar.
Brief facts
E.R. Squibb and Sons and its group companies, patentees of an Indian patent for monoclonal antibodies used in a cancer immunotherapy drug, filed a quia timet suit against Zydus Lifesciences to restrain manufacture and sale of a biosimilar.
Free to read once you are signed in
Read the rest of this case note
The findings, the decision and the principle the court settled on are below. Create a free account to keep reading. No payment, and nothing to cancel.
Already have an account? Sign in
We use your details to give you access and to contact you about your enquiry. See our privacy policy.
Keywords
Biotechnology Interim Injunction Patent Infringement Pharmaceutical Patent Pre-grant Opposition
Read the judgment
More Patents judgments
Patents
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBigtec Private Limited v. Assistant Controller of Patents and Designs
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for …
BiotechnologyInventive StepPatent ProsecutionPrior Art